COVID antiviral eligibility: navigating the maze

Press/Media: Expert Comment

Description

Article describing the discrepancies in appropriate use criteria for COVID-19 antiviral therapies

Subject

Pharmaceutical Benefits System

National COVID-19 Clinical Evidence Taskforce

Antiviral

COVID-19

Period13 Jun 2022

Media contributions

1

Media contributions

  • TitleCOVID antiviral eligibility: navigating the maze
    Degree of recognitionNational
    Media name/outletMedical Journal of Australia InSight+
    Media typeWeb
    Country/TerritoryAustralia
    Date13/06/22
    DescriptionArticle describing the COVID-19 antiviral therapy appropriate use criteria.
    Producer/AuthorCate Swannell
    PersonsMark Morgan